JP2015007131A5 - - Google Patents

Download PDF

Info

Publication number
JP2015007131A5
JP2015007131A5 JP2014208291A JP2014208291A JP2015007131A5 JP 2015007131 A5 JP2015007131 A5 JP 2015007131A5 JP 2014208291 A JP2014208291 A JP 2014208291A JP 2014208291 A JP2014208291 A JP 2014208291A JP 2015007131 A5 JP2015007131 A5 JP 2015007131A5
Authority
JP
Japan
Prior art keywords
formulation
oral solid
active ingredient
oral
outer layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014208291A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015007131A (ja
JP6054931B2 (ja
Filing date
Publication date
Priority claimed from EP08290529A external-priority patent/EP2133071A1/en
Application filed filed Critical
Publication of JP2015007131A publication Critical patent/JP2015007131A/ja
Publication of JP2015007131A5 publication Critical patent/JP2015007131A5/ja
Application granted granted Critical
Publication of JP6054931B2 publication Critical patent/JP6054931B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014208291A 2008-06-09 2014-10-09 胃保持型製剤の製造法 Expired - Fee Related JP6054931B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08290529.0 2008-06-09
EP08290529A EP2133071A1 (en) 2008-06-09 2008-06-09 Process for making gastroretentive dosage forms

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011513066A Division JP5675598B2 (ja) 2008-06-09 2009-06-08 胃保持型製剤の製造法

Publications (3)

Publication Number Publication Date
JP2015007131A JP2015007131A (ja) 2015-01-15
JP2015007131A5 true JP2015007131A5 (https=) 2015-03-19
JP6054931B2 JP6054931B2 (ja) 2016-12-27

Family

ID=40219495

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011513066A Expired - Fee Related JP5675598B2 (ja) 2008-06-09 2009-06-08 胃保持型製剤の製造法
JP2014208291A Expired - Fee Related JP6054931B2 (ja) 2008-06-09 2014-10-09 胃保持型製剤の製造法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011513066A Expired - Fee Related JP5675598B2 (ja) 2008-06-09 2009-06-08 胃保持型製剤の製造法

Country Status (7)

Country Link
US (1) US9060930B2 (https=)
EP (2) EP2133071A1 (https=)
JP (2) JP5675598B2 (https=)
CN (1) CN102105139B (https=)
CA (1) CA2727206A1 (https=)
ES (1) ES2561478T3 (https=)
WO (1) WO2009150514A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
EP2444064A1 (en) * 2010-10-22 2012-04-25 Meliatys Process for making multiparticulate gastroretentive dosage forms
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
WO2013114390A1 (en) * 2012-01-02 2013-08-08 Medreich Limited Gastro retentive drug delivery system of calcium supplements
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN103462926B (zh) * 2013-09-23 2015-09-16 淄博齐鼎立专利信息咨询有限公司 一种泛昔洛韦片剂及其制备方法
EP3148514B1 (en) 2014-06-02 2024-04-17 Clexio Biosciences Ltd. Expandable gastroretentive dosage form
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3547974B1 (en) 2016-12-02 2023-11-15 Clexio Biosciences Ltd. Gastric residence system
JP7296084B2 (ja) 2017-12-04 2023-06-22 クレキシオ バイオサイエンシーズ エルティーディー. 長時間作用型胃滞留システム
US11337919B2 (en) * 2017-12-18 2022-05-24 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release
CN116459226B (zh) * 2023-04-26 2025-04-18 重庆康刻尔制药股份有限公司 一种铝碳酸镁双层片及其制备方法
CN118526484A (zh) * 2024-07-26 2024-08-23 中国中医科学院中药研究所 青蒿琥酯或双氢青蒿素在制备改善罗格列酮不良反应制剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL149493B1 (en) 1985-04-12 1990-02-28 Method of obtaining a tablet capable to buoy over surface of gastric juice
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
US4814178A (en) 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
US5169638A (en) 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
AU2001232020A1 (en) * 2000-02-09 2001-08-20 West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited Floating drug delivery composition
JP2001270827A (ja) 2000-03-23 2001-10-02 Eisai Co Ltd ベンズイミダゾール系化合物含有錠剤
JP2002154948A (ja) * 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
EP1478345A4 (en) * 2002-01-03 2010-11-17 Glaxosmithkline Llc NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
WO2004002445A2 (en) * 2002-06-26 2004-01-08 Cadila Healthcare Limited Novel floating dosage form
WO2007137216A2 (en) * 2006-05-22 2007-11-29 Janssen Pharmaceutica, N.V. Gastroretentive sustained release formulations
ES2368356T3 (es) * 2007-07-06 2011-11-16 Basf Corporation Composición de retención gástrica basada en un producto de reacción hidrosoluble procedente de un precursor que contiene un grupo vinilo.

Similar Documents

Publication Publication Date Title
JP2015007131A5 (https=)
JP2015078230A5 (https=)
JP2012255026A5 (https=)
ES2409069B2 (es) Uso de aglutinantes para fabricar formulaciones estables al almacenamiento
JP2015504081A5 (https=)
JP2014221779A5 (https=)
JP2014129360A5 (https=)
JP2013545785A5 (https=)
JP2017537066A5 (https=)
JP2013509429A5 (https=)
JP2013510216A5 (https=)
JP2007302683A5 (https=)
JP2011037901A5 (https=)
JP2018162276A5 (https=)
JP2011527299A5 (https=)
JP2011518833A5 (https=)
JP2017533930A5 (https=)
RU2014127142A (ru) Фармацевтическая композиция с улучшенной биодоступностью для высокоплавкого гидрофобного соединения
JP2011184444A5 (https=)
EP4454708A3 (en) A tablet comprising a methoxyurea derivative and mannitol particles
JP2010540547A5 (https=)
JP2019510079A5 (https=)
JP2013513607A5 (https=)
PL401676A1 (pl) Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania
RU2015138784A (ru) Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов